Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $289 | In Stock | |
5 mg | $755 | In Stock | |
10 mg | $1,190 | In Stock | |
25 mg | $1,780 | In Stock | |
50 mg | $2,430 | In Stock | |
100 mg | $3,270 | In Stock |
Description | Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site. Injections of Concizumab increase thrombin in blood, thereby preventing and treating hemophilia. |
In vitro | In a concentration-dependent manner, Concizumab increases the peak value of thrombin [1]. |
In vivo | In cynomolgus monkeys, Concizumab (i.v./s.c.) blocked the interaction between TFPI and FXa active site [2]. |
Alias | mAb 2021, NN 7415 |
Cas No. | 1312299-39-0 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.